Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

327 public trials 104 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +12 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
  • Southern Oncology Clinical Research Unit Adelaide, Australia
  • Austin Health Melbourne, Australia
View all 19 locations
View Trial Details
Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
Locations
  • City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 185 locations
View Trial Details
Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

NCT06428409

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
Locations
  • UCLA ( Site 0317) Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus ( Site 0299) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0325) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0326) Aurora, Colorado, United States
View all 55 locations
View Trial Details

Related conditions